Adeyemo, A., Balaconis, M. K., Darnes, D. R., Fatumo, S., Granados Moreno, P., Hodonsky, C. J., Inouye, M., Kanai, M., Kato, K., Knoppers, B. M., Lewis, A. C. F., Martin, A. R., McCarthy, M. I., Meyer, M. N., Okada, Y., Richards, J. B., Richter, L., Ripatti, S., Rotimi, C. N., … Polygenic Risk Score Task Force of the International Common Disease Alliance. (2021). Responsible use of polygenic risk scores in the clinic: Potential benefits, risks and gaps. Nature Medicine, 27(11), 1876–1884. https://doi.org/10.1038/s41591-021-01549-6
Araújo, D. S., & Wheeler, H. E. (2022). Genetic and environmental variation impact transferability of polygenic risk scores. Cell Reports Medicine, 3(7), 100687. https://doi.org/10.1016/j.xcrm.2022.100687
Bafligil, C., Thompson, D. J., Lophatananon, A., Ryan, N. A. J., Smith, M. J., Dennis, J., Mekli, K., O'Mara, T. A., Evans, D. G., & Crosbie, E. J. (2022). Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European women. Genetics in Medicine, 24(9), 1847–1856. https://doi.org/10.1016/j.gim.2022.05.014
Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., Kohlmann, W. K., Kurian, A. W., Laronga, C., Lynce, F., Norquist, B. S., Plichta, J. K., Rodriguez, P., Shah, P. D., Tischkowitz, M., Wood, M., Yadav, S., Yao, K., & Robson, M. E. (2024). Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline. Journal of Clinical Oncology, 42(5), 584–604. https://doi.org/10.1200/JCO.23.02225
Borry, P., Stultiens, L., Nys, H., Cassiman, J.-J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clinical Genetics, 70(5), 374–381. https://doi.org/10.1111/j.1399-0004.2006.00692.x
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
Breast Cancer. (n.d.). Europa Donna. Retrieved October 24, 2023, from https://www.europadonna.org/breast-cancer/
Brown, J. E. H., Young, J. L., & Martinez-Martin, N. (2022). Psychiatric genomics, mental health equity, and intersectionality: A framework for research and practice. Frontiers in Psychiatry, 13, 1061705. https://doi.org/10.3389/fpsyt.2022.1061705
Cardiovascular diseases (CVDs). (n.d.). Retrieved October 24, 2023, from https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Chapman, C. R. (2022). Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: A narrative review identifying concerns about interpretation and use of polygenic scores. Journal of Community Genetics, 14, 441–452. https://doi.org/10.1007/s12687-022-00625-9
Chowdhury, S., Dent, T., Pashayan, N., Hall, A., Lyratzopoulos, G., Hallowell, N., Hall, P., Pharoah, P., & Burton, H. (2013). Incorporating genomics into breast and prostate cancer screening: Assessing the implications. Genetics in Medicine, 15(6), 423–432. https://doi.org/10.1038/gim.2012.167
Clarke, A. J., & van El, C. G. (2022). Genomics and justice: Mitigating the potential harms and inequities that arise from the implementation of genomics in medicine. Human Genetics, 141(5), 1099–1107. https://doi.org/10.1007/s00439-022-02453-w
Docherty, A., Kious, B., Brown, T., Francis, L., Stark, L., Keeshin, B., Botkin, J., DiBlasi, E., Gray, D., & Coon, H. (2021). Ethical concerns relating to genetic risk scores for suicide. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 186(8), 433–444. https://doi.org/10.1002/ajmg.b.32871
Driver, M. N., Kuo, S. I.-C., & Dick, D. M. (2023). Returning complex genetic risk information to promote better health-related behaviors: A commentary of the literature and suggested next steps. Translational Behavioral Medicine, 13(2), 115–119. https://doi.org/10.1093/tbm/ibac071
Eeltink, E., van der Horst, M. Z., Zinkstok, J. R., Aalfs, C. M., & Luykx, J. J. (2021). Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine. Neuroscience and Biobehavioral Reviews, 121, 119–127. https://doi.org/10.1016/j.neubiorev.2020.11.021
Fahed, A. C., Wang, M., Homburger, J. R., Patel, A. P., Bick, A. G., Neben, C. L., Lai, C., Brockman, D., Philippakis, A., Ellinor, P. T., Cassa, C. A., Lebo, M., Ng, K., Lander, E. S., Zhou, A. Y., Kathiresan, S., & Khera, A. V. (2020). Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nature Communications, 11, 3635. https://doi.org/10.1038/s41467-020-17374-3
Folkersen, L., Pain, O., Ingason, A., Werge, T., Lewis, C. M., & Austin, J. (2020). Impute.me: An open-source, non-profit tool for using data from direct-to-consumer genetic testing to calculate and interpret polygenic risk scores. Frontiers in Genetics, 11, 578. https://doi.org/10.3389/fgene.2020.00578
Fritzsche, M.-C., Akyüz, K., Cano Abadía, M., McLennan, S., Marttinen, P., Mayrhofer, M. T., & Buyx, A. M. (2023). Ethical layering in AI-driven polygenic risk scores-New complexities, new challenges. Frontiers in Genetics, 14, 1098439. https://doi.org/10.3389/fgene.2023.1098439
Griffin, S. (2022). Diabetes precision medicine: Plenty of potential, pitfalls and perils but not yet ready for prime time. Diabetologia, 65(11), 1913–1921. https://doi.org/10.1007/s00125-022-05782-7
Ikeda, M., Saito, T., Kanazawa, T., & Iwata, N. (2021). Polygenic risk score as clinical utility in psychiatry: A clinical viewpoint. Journal of Human Genetics, 66(1), 53–60. https://doi.org/10.1038/s10038-020-0814-y
Isgut, M., Sun, J., Quyyumi, A. A., & Gibson, G. (2021). Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later. Genome Medicine, 13(1), 13. https://doi.org/10.1186/s13073-021-00828-8
Johansson, Å., Andreassen, O. A., Brunak, S., Franks, P. W., Hedman, H., Loos, R. J. F., Meder, B., Melén, E., Wheelock, C. E., & Jacobsson, B. (2023). Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification. Journal of Internal Medicine, 294(4), 378–396. https://doi.org/10.1111/joim.13640
Johnson, N., & Phillips, M. (2018). Rayyan for systematic reviews. Journal of Electronic Resources Librarianship, 30(1), 46–48. https://doi.org/10.1080/1941126X.2018.1444339
Kaplan, J. M., & Fullerton, S. M. (2022). Polygenic risk, population structure and ongoing difficulties with race in human genetics. Philosophical Transactions of the Royal Society B: Biological Sciences, 377(1852), 20200427. https://doi.org/10.1098/rstb.2020.0427
Khoury, M. J., Janssens, A. C. J. W., & Ransohoff, D. F. (2013). How can polygenic inheritance be used in population screening for common diseases? Genetics in Medicine: Official Journal of the American College of Medical Genetics, 15(6), 437–443. https://doi.org/10.1038/gim.2012.182
Klarin, D., & Natarajan, P. (2022). Clinical utility of polygenic risk scores for coronary artery disease. Nature Reviews Cardiology, 19(5), 291–301. https://doi.org/10.1038/s41569-021-00638-w
Koch, S., Schmidtke, J., Krawczak, M., & Caliebe, A. (2023). Clinical utility of polygenic risk scores: A critical 2023 appraisal. Journal of Community Genetics, 14(5), 471–487. https://doi.org/10.1007/s12687-023-00645-z
Knoppers, B. M., Bernier, A., Granados Moreno, P., & Pashayan, N. (2021). Of Screening, Stratification, and Scores. Journal of Personalized Medicine, 11(8), 736. https://doi.org/10.3390/jpm11080736
Kullo, I. J., Lewis, C. M., Inouye, M., Martin, A. R., Ripatti, S., & Chatterjee, N. (2022). Polygenic scores in biomedical research. Nature Reviews. Genetics, 23(9), 524–532. https://doi.org/10.1038/s41576-022-00470-z
Kumuthini, J., Zick, B., Balasopoulou, A., Chalikiopoulou, C., Dandara, C., El-Kamah, G., Findley, L., Katsila, T., Li, R., Maceda, E. B., Monye, H., Rada, G., Thong, M.-K., Wanigasekera, T., Kennel, H., Marimuthu, V., Williams, M. S., Al-Mulla, F., & Abramowicz, M. (2022). The clinical utility of polygenic risk scores in genomic medicine practices: A systematic review. Human Genetics, 141(11), 1697–1704. https://doi.org/10.1007/s00439-022-02452-x
Lanchbury, J. S., & Pederson, H. J. (2023). An apparent quandary: Adoption of polygenics and gene panels for personalised breast cancer risk stratification. BJC Reports, 1(1), 15. https://doi.org/10.1038/s44276-023-00014-w
Lewis, A. C. F., & Green, R. C. (2021). Polygenic risk scores in the clinic: New perspectives needed on familiar ethical issues. Genome Medicine, 13(1), 14. https://doi.org/10.1186/s13073-021-00829-7
Lewis, A. C. F., Perez, E. F., Prince, A. E. R., Flaxman, H. R., Gomez, L., Brockman, D. G., Chandler, P. D., Kerman, B. J., Lebo, M. S., Smoller, J. W., Weiss, S. T., Blout Zawatksy, C. L., Meigs, J. B., Green, R. C., Vassy, J. L., & Karlson, E. W. (2022). Patient and provider perspectives on polygenic risk scores: Implications for clinical reporting and utilization. Genome Medicine, 14(1), 114. https://doi.org/10.1186/s13073-022-01117-8
Lewis, C. M., & Vassos, E. (2020). Polygenic risk scores: From research tools to clinical instruments. Genome Medicine, 12(1), 44. https://doi.org/10.1186/s13073-020-00742-5
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6(7), e1000100. https://doi.org/10.1371/journal.pmed.1000100
Lu, T., Zhou, S., Wu, H., Forgetta, V., Greenwood, C. M. T., & Richards, J. B. (2021). Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening. Genetics in Medicine, 23(3), 508–515. https://doi.org/10.1038/s41436-020-01007-7
Manolio, T. A. (2010). Genomewide association studies and assessment of the risk of disease. The New England Journal of Medicine, 363(2), 166–176. https://doi.org/10.1056/NEJMra0905980
Manrique de Lara, A., Soto-Gómez, L., Núñez-Acosta, E., Saruwatari-Zavala, G., & Rentería, M. E. (2019). Ethical issues in susceptibility genetic testing for late-onset neurodegenerative diseases. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 180(8), 609–621. https://doi.org/10.1002/ajmg.b.32699
Mars, N., Lindbohm, J. V., Della Briotta Parolo, P., Widen, E., Kaprio, J., Palotie, A., FinnGen, & Ripatti, S. (2022). Systematic comparison of family history and polygenic risk across 24 common diseases. American Journal of Human Genetics, 109(12), 2152–2162. https://doi.org/10.1016/j.ajhg.2022.10.009
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019). Clinical use of current polygenic risk scores may exacerbate health disparities. Nature Genetics, 51(4), 584–591. https://doi.org/10.1038/s41588-019-0379-x
Mathieu, C., Soderberg, J., Del Prato, S., Felton, A.-M., Cos, X., de Beaufort, C., Gautier, J.-F., Hauck, B., Forbes, A., Heine, R., Schwarz, P., Torbeyns, B., & European Diabetes Forum. (2023). The European Diabetes Forum (EUDF): A forum for turning the tide on diabetes in Europe. Diabetologia, 66(2), 247–252. https://doi.org/10.1007/s00125-022-05831-1
Moore, A. M., & Richer, J. (2022). Genetic testing and screening in children. Paediatrics & Child Health, 27(4), 243–247. https://doi.org/10.1093/pch/pxac028
Moorthie, S., de Villiers, C. B., Brigden, T., Louise Gaynor, L., Hall, A., Johnson, E., Sanderson, S., & Kroese, M. (2019). Polygenic scores, risk and cardiovascular disease. PHG Foundation.
Newson, A. J. (2022). The promise of public health ethics for precision medicine: The case of newborn preventive genomic sequencing. Human Genetics, 141(5), 1035–1043. https://doi.org/10.1007/s00439-021-02269-0
O'Sullivan, J. W., Raghavan, S., Marquez-Luna, C., Luzum, J. A., Damrauer, S. M., Ashley, E. A., O'Donnell, C. J., Willer, C. J., & Natarajan, P. (2022). Polygenic risk scores for cardiovascular disease: A scientific statement from the American Heart Association. Circulation, 146(8), e93–e118. https://doi.org/10.1161/CIR.0000000000001077
Palk, A. C., Dalvie, S., de Vries, J., Martin, A. R., & Stein, D. J. (2019). Potential use of clinical polygenic risk scores in psychiatry – Ethical implications and communicating high polygenic risk. Philosophy, Ethics, and Humanities in Medicine: PEHM, 14, 4. https://doi.org/10.1186/s13010-019-0073-8
Pashayan, N., Hall, A., Chowdhury, S., Dent, T., Pharoah, P. D. P., & Burton, H. (2013). Public health genomics and personalized prevention: Lessons from the COGS project. Journal of Internal Medicine, 274(5), 451–456. https://doi.org/10.1111/joim.12094
Peay, H. L. (2020). Genetic risk assessment in psychiatry. Cold Spring Harbor Perspectives in Medicine, 10(12), a036616. https://doi.org/10.1101/cshperspect.a036616
Pinzon-Espinosa, J., van der Horst, M., Zinkstok, J., Austin, J., Aalfs, C., Batalla, A., Sullivan, P., Vorstman, J., & Luykx, J. (2022). Barriers to genetic testing in clinical psychiatry and ways to overcome them: From clinicians' attitudes to sociocultural differences between patients across the globe. Translational Psychiatry, 12(1), 442. https://doi.org/10.1038/s41398-022-02203-6
Plomin, R., & von Stumm, S. (2022). Polygenic scores: Prediction versus explanation. Molecular Psychiatry, 27(1), 49–52. https://doi.org/10.1038/s41380-021-01348-y
Rashkin, M. D., Bowes, J., Dunaway, K., Dhaliwal, J., Loomis, E., Riffle, S., Washington, N. L., Ziegler, C., Lu, J., & Levin, E. (2019). Genetic counseling, 2030: An on-demand service tailored to the needs of a price conscious, genetically literate, and busy world. Journal of Genetic Counseling, 28(2), 456–465. https://doi.org/10.1002/jgc4.1123
Reid, N. J., Brockman, D. G., Elisabeth Leonard, C., Pelletier, R., & Khera, A. V. (2021). Concordance of a High Polygenic Score Among Relatives: Implications for Genetic Counseling and Cascade Screening. Circulation. Genomic and Precision Medicine, 14(2), e003262. https://doi.org/10.1161/CIRCGEN.120.003262
Roberts, M. C., Khoury, M. J., & Mensah, G. A. (2019). Perspective: The clinical use of polygenic risk scores: Race, ethnicity, and health disparities. Ethnicity & Disease, 29(3), 513–516. https://doi.org/10.18865/ed.29.3.513
Ronald, A. (2020). Editorial: Polygenic scores in child and adolescent psychiatry – Strengths, weaknesses, opportunities and threats. Journal of Child Psychology and Psychiatry, 61(5), 519–521. https://doi.org/10.1111/jcpp.13246
Rothstein, M. A. (2018). Reconsidering the duty to warn genetically at-risk relatives. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 20(3), 285–290. https://doi.org/10.1038/gim.2017.257
Sabatello, M., & Juengst, E. (2019). Genomic essentialism: Its provenance and trajectory as an anticipatory ethical concern. Hastings Center Report, 49(S1), S10–S18. https://doi.org/10.1002/hast.1012
Sharif Nia, H., Sivarajan-Froelicher, E., Haghdoost, A. A., Moosazadeh, M., Huak-Chan, Y., Farsavian, A. A., Nazari, R., Yaghoobzadeh, A., & Goudarzian, A. H. (2018). The estimate of average age at the onset of acute myocardial infarction in Iran: A systematic review and meta-analysis study. ARYA Atherosclerosis, 14(5), 225–232. https://doi.org/10.22122/arya.v14i5.1739
Slunecka, J. L., van der Zee, M. D., Beck, J. J., Johnson, B. N., Finnicum, C. T., Pool, R., Hottenga, J.-J., de Geus, E. J. C., & Ehli, E. A. (2021). Implementation and implications for polygenic risk scores in healthcare. Human Genomics, 15(1), 46. https://doi.org/10.1186/s40246-021-00339-y
Sofaer, N., & Strech, D. (2012). The need for systematic reviews of reasons. Bioethics, 26(6), 315–328. https://doi.org/10.1111/j.1467-8519.2011.01858.x
Strech, D., & Sofaer, N. (2012). How to write a systematic review of reasons. Journal of Medical Ethics, 38(2), 121–126. https://doi.org/10.1136/medethics-2011-100096
Sud, A., Horton, R. H., Hingorani, A. D., Tzoulaki, I., Turnbull, C., Houlston, R. S., & Lucassen, A. (2023). Realistic expectations are key to realising the benefits of polygenic scores. BMJ, 380, e073149. https://doi.org/10.1136/bmj-2022-073149
Terek, S., Del Rosario, M. C., Hain, H. S., Connolly, J. J., Behr, M. A., Harr, M., Hakonarson, H., & Holm, I. A. (2022). Attitudes among parents towards return of disease-related polygenic risk scores (PRS) for their children. Journal of Personalized Medicine, 12(12), 1945. https://doi.org/10.3390/jpm12121945
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018). The personal and clinical utility of polygenic risk scores. Nature Reviews Genetics, 19(9), 581–590. https://doi.org/10.1038/s41576-018-0018-x
Wand, H., Kalia, S. S., Helm, B. M., Suckiel, S. A., Brockman, D., Vriesen, N., Goudar, R. K., Austin, J., & Yanes, T. (2023). Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A practice resource from the National Society of Genetic Counselors. Journal of Genetic Counseling, 32(3), 558–575. https://doi.org/10.1002/jgc4.1668
Yanes, T., McInerney-Leo, A. M., Law, M. H., & Cummings, S. (2020). The emerging field of polygenic risk scores and perspective for use in clinical care. Human Molecular Genetics, 29(R2), R165–R176. https://doi.org/10.1093/hmg/ddaa136
Yanes, T., Young, M.-A., Meiser, B., & James, P. A. (2020). Clinical applications of polygenic breast cancer risk: A critical review and perspectives of an emerging field. Breast Cancer Research, 22(1), 21. https://doi.org/10.1186/s13058-020-01260-3
